BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14499309)

  • 1. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis.
    Maclean R; Ward PE; Glen I; Roberts SJ; Ross BM
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):927-33. PubMed ID: 14499309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
    Ross BM; Hughes B; Turenne S; Seeman M; Warsh JJ
    Eur Neuropsychopharmacol; 2004 May; 14(3):191-7. PubMed ID: 15056478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
    Smesny S; Rosburg T; Riemann S; Baur K; Rudolph N; Berger G; Sauer H
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
    Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
    Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder.
    Smesny S; Baur K; Rudolph N; Nenadic I; Sauer H
    J Affect Disord; 2010 Aug; 124(3):335-40. PubMed ID: 20116108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis.
    Glahn DC; Bearden CE; Cakir S; Barrett JA; Najt P; Serap Monkul E; Maples N; Velligan DI; Soares JC
    Bipolar Disord; 2006 Apr; 8(2):117-23. PubMed ID: 16542181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: A preliminary investigation.
    Ross BM
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():99-102. PubMed ID: 28552466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolinemia is a risk factor for schizoaffective disorder.
    Jacquet H; Demily C; Houy E; Hecketsweiler B; Bou J; Raux G; Lerond J; Allio G; Haouzir S; Tillaux A; Bellegou C; Fouldrin G; Delamillieure P; Ménard JF; Dollfus S; D'Amato T; Petit M; Thibaut F; Frébourg T; Campion D
    Mol Psychiatry; 2005 May; 10(5):479-85. PubMed ID: 15494707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
    Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
    Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL
    Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
    Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
    J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The niacin skin flush test in schizophrenia: a replication study.
    Puri BK; Easton T; Das I; Kidane L; Richardson AJ
    Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
    Dean B; Digney A; Sundram S; Thomas E; Scarr E
    Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
    Messamore E; Hoffman WF; Yao JK
    Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model.
    Levine J; Sela BA; Osher Y; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1181-91. PubMed ID: 16115716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.